| MR编号 | NL/H/2469/001 |
|---|
| 药品名称 | Etoposide Fresenius Kabi 20 mg/ml,
concentrate for solution for infusion |
|---|
| 活性成分 | |
|---|
| 剂型 | Concentrate for solution for infusion |
|---|
| 上市许可持有人 | Fresenius Kabi Nederland B.V.
Amersfoortseweg 10 E
3712 BC
Huis ter Heide
The Netherlands |
|---|
| 参考成员国 - 产品名称 | Netherlands (NL) Etoposide Fresenius Kabi 20 mg/ml, concentraat voor oplossing voor infusie |
|---|
| 互认成员国 - 产品名称 | - Denmark (DK)
Etoposid "Fresenius Kabi" - Belgium (BE)
Etoposide Fresenius Kabi 20mg/ml concentraat voor oplossing voor infusie - United Kingdom (Northern Ireland) (XI)
- Ireland (IE)
- Austria (AT)
Etoposid Kabi 20 mg/ml Konzentrat zur Herstellung einer Infusionslösung - Sweden (SE)
- Norway (NO)
Etoposid Fresenius Kabi - Finland (FI)
- Latvia (LV)
Etoposide Kabi 20 mg/ml koncentrāts infūziju šķīduma pagatavošanai - Lithuania (LT)
Etoposide Kabi 20 mg/ml koncentratas infuziniam tirpalui - Estonia (EE)
ETOPOSIDE KABI 20 MG/ML - Hungary (HU)
ETOPOSIDE KABI 20 mg/ml koncentrátum oldatos infúzióhoz - Romania (RO)
Etoposid Kabi 20 mg/ml concentrat pentru soluţie perfuzabilă - Slovenia (SI)
|
|---|
| 许可日期 | 2014/03/13 |
|---|
| 最近更新日期 | 2025/08/04 |
|---|
| 药物ATC编码 | | 申请类型 | - TypeLevel1：Abridged
- TypeLevel2：Initial Application
- TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
- TypeLevel4：Chemical Substance
- TypeLevel5：Prescription Only
|
|---|
| 附件文件下载 | |
|---|
| 市场状态 | Positive |
|---|
|
|---|